Elif A Oral Selected Research

Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy)

1/2021	Effect of Leptin Therapy on Survival in Generalized and Partial Lipodystrophy: A Matched Cohort Analysis.
11/2019	Comorbidities and Survival in Patients With Lipodystrophy: An International Chart Review Study.
1/2019	Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to Metreleptin.
1/2018	A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation.
1/2018	Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy.
1/2018	Potential association of LMNA-associated generalized lipodystrophy with juvenile dermatomyositis.
12/2016	The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.
1/2016	Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy.
11/2015	A Report of Three Cases With Acquired Generalized Lipodystrophy With Distinct Autoimmune Conditions Treated With Metreleptin.
3/2010	Rationale for leptin-replacement therapy for severe lipodystrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elif A Oral Research Topics

Disease

16	Lipodystrophy 01/2021 - 09/2004
10	Insulin Resistance 12/2021 - 02/2009
10	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 01/2021 - 03/2010
7	Obesity 01/2021 - 02/2012
7	Hypertriglyceridemia 03/2020 - 11/2015
5	Type 2 Diabetes Mellitus (MODY) 12/2019 - 01/2011
4	Diabetes Mellitus 12/2019 - 01/2018
4	Weight Loss (Weight Reduction) 11/2018 - 01/2017
3	Familial Partial Lipodystrophy (Dunnigan Syndrome) 12/2021 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 08/2013
3	Non-alcoholic Fatty Liver Disease 01/2021 - 05/2017
2	Hyperglycemia 01/2021 - 01/2016
2	Disease Progression 03/2020 - 11/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 01/2017
2	Hyperlipidemias (Hyperlipidemia) 11/2018 - 12/2016
1	Atrial Fibrillation 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Hyperinsulinism (Hyperinsulinemia) 01/2021
1	Tachycardia (Tachyarrhythmias) 01/2021
1	Heart Diseases (Heart Disease) 03/2020
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019
1	Hyperprolactinemia 01/2019
1	Hypothyroidism 01/2019
1	Alcoholic Fatty Liver 01/2019
1	Subcutaneous panniculitis-like T-cell lymphoma 01/2019
1	Diabetes Insipidus 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Hypertension (High Blood Pressure) 11/2018
1	Hepatomegaly 01/2018
1	Muscular Dystrophies (Muscular Dystrophy) 01/2018
1	Pancreatitis 01/2018
1	Progeria (Hutchinson Gilford Syndrome) 01/2018
1	Acanthosis Nigricans 01/2018
1	Laminopathies 01/2018
1	Metabolic Diseases (Metabolic Disease) 07/2017
1	Inflammation (Inflammations) 07/2017
1	Fatty Liver 07/2017
1	Fibrosis (Cirrhosis) 05/2017
1	Hyperplasia 01/2017
1	Urinary Tract Infections (Urinary Tract Infection) 03/2016
1	Nausea 03/2016
1	Hypoglycemia (Reactive Hypoglycemia) 03/2016
1	Injection Site Reaction 01/2016
1	Hyperphagia (Overeating) 11/2015
1	Autoimmune Diseases (Autoimmune Disease) 11/2015
1	Chronic Urticaria 11/2015
1	Autoimmune Hepatitis 11/2015
1	Graves Disease (Basedow Disease) 11/2015
1	Dermatomyositis (Dermatopolymyositis) 11/2015

Drug/Important Bio-Agent (IBA)

21	LeptinIBA 01/2021 - 09/2004
11	metreleptinIBA 01/2021 - 03/2010
6	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2011
5	Triglycerides (Triacylglycerol)IBA 03/2020 - 03/2010
4	Insulin (Novolin)FDA Link 01/2019 - 08/2014
2	Lamin Type A (Lamin A)IBA 01/2021 - 01/2018
2	Neutralizing AntibodiesIBA 03/2020 - 01/2016
2	recombinant methionyl human leptinIBA 01/2019 - 09/2004
2	HDL CholesterolIBA 01/2018 - 09/2011
2	LaminsIBA 01/2018 - 01/2018
2	amlexanox (Aphthasol)FDA Link 07/2017 - 01/2015
2	EnzymesIBA 03/2016 - 11/2015
1	vupanorsenIBA 12/2021
1	AngiopoietinsIBA 12/2021
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2021
1	AdiponectinIBA 01/2021
1	Codon (Codons)IBA 01/2021
1	IronIBA 01/2021
1	Leptin ReceptorsIBA 03/2020
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 03/2020
1	setmelanotideIBA 03/2020
1	Liraglutide FDA Link 01/2019
1	Transaminases (Aminotransferases)IBA 01/2019
1	AntioxidantsIBA 01/2019
1	Growth Hormone (Somatotropin)IBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 11/2018
1	CholesterolIBA 11/2018
1	MicronutrientsIBA 12/2017
1	Pharmaceutical PreparationsIBA 07/2017
1	Phosphotransferases (Kinase)IBA 07/2017
1	nasIBA 05/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2016
1	Metformin (Glucophage)FDA LinkGeneric 12/2016
1	Fibric Acids (Fibrates)IBA 12/2016
1	Blood Glucose (Blood Sugar)IBA 01/2016
1	AntibodiesIBA 01/2016
1	empagliflozinIBA 01/2016
1	pramlintide (Symlin)FDA Link 01/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2015
1	erucylphosphocholineIBA 08/2013

Therapy/Procedure

16	Therapeutics 01/2021 - 03/2010
4	Gastric Bypass (Roux-en-Y Gastric Bypass) 11/2018 - 01/2017
3	Glycemic Control 01/2019 - 03/2010
3	Gastrectomy 11/2018 - 01/2017
2	Bariatric Surgery 12/2019 - 12/2017
2	Injections 12/2016 - 09/2004
1	Defibrillators (Defibrillator) 03/2020
1	Radiofrequency Ablation 01/2019
1	Drug Therapy (Chemotherapy) 01/2019